Form 4 for EHC Encompass Health Corp
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-28 · accession 0000785161-26-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-02-28 | EHC | Tarr Mark J | Pres, CEO, Dir | F - Tax | $107.88 | -2,187 | 441.0K | -0.5% | -$235.9K |
| D | 2026-03-03 | 2026-03-02 | EHC | Tarr Mark J | Pres, CEO, Dir | A - Grant | $108.06 | +35.5K | 35.5K | New | +$3.83M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Encompass Health Common Stock | 2026-02-28 | F | D | 2,187 | $107.88 | 440,962 | D | — | — | (F1) These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. |
| 2 | Derivative | Non-qualified Stock Option (Right to Buy) | 2026-03-02 | A | A | 35,461 | $108.06 | 35,461 | D | $108.06 · 2027-03-02 to 2036-03-02 | 35,461 Encompass Health Common Stock | (F2) The option becomes exercisable in equal annual installments over a three-year period commencing March 2, 2027. |